Answers are grounded in this paper and cite their sources.
Patients with hematologic malignancies treated in the setting of a universal health care system who experience FT have a worse HRQoL profile compared with those without FT.
No takes yet. Share an insight, caveat, or question.
Sparano et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: